By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
9
Notification Show More
News
Morgan Stanley says wealthy clients ‘bought the dip’ amid tariff turmoil
20 minutes ago
News
Gaza stampede at GHF aid site kills at least 20
1 hour ago
News
Bank of America boosted by bigger loan book and robust trading
2 hours ago
News
Diageo to replace chief executive Debra Crew after share price slump
3 hours ago
News
Nvidia chief vows to ‘accelerate recovery’ of China sales as H20 chip ban lifted
4 hours ago
News
How a decade-old Italian scandal landed at door of Deutsche Bank’s CEO
5 hours ago
News
‘Fire’ is now the greater threat to investors than ‘ice’
6 hours ago
News
Brussels pushes schools to serve ‘made in Europe’ fruit and vegetables
7 hours ago
News
Brussels moves to placate Paris over South American trade deal
8 hours ago
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > Investing > Canada Reveals Drug Plan, Estimated Annual Cost in C$1.5 Billion Range
Investing

Canada Reveals Drug Plan, Estimated Annual Cost in C$1.5 Billion Range

News Room
Last updated: 2024/03/01 at 8:56 AM
By News Room
Share
3 Min Read
SHARE

By Paul Vieira


OTTAWA- Canada’s minority Liberal government on Thursday revealed a slimmed-down version of a single-payer universal drug plan, with an initial price tag that represents a fraction of the cost that budget watchers anticipated.

The drug plan meets a demand by a smaller left-wing party, the New Democratic Party, in exchange for its support in the legislature to prop up the minority Liberal administration. Canada’s parliamentary budget watchdog had estimated the annual cost of a universal drug plan – which would cover a gamut of medicines – starting at about 11 billion Canadian dollars, or the equivalent of $8.1 billion.

The initial proposal, as set out in legislation introduced Thursday, intends to initially cover a number of birth-control and diabetes medications. Canada Health Minister Mark Holland told reporters an early estimate of the annual cost could be in the C$1.5 billion range, although he warned that could change. “It’s not an insignificant cost.”

He added the cost is contingent on what’s negotiated with each of the individual provinces and territories, which in Canada have jurisdiction over delivering health care to residents. Holland added he didn’t expect Finance Minister Chrystia Freeland to book a cost in the 2024-25 fiscal year for the drug plan when the annual budget plan is revealed, expected in the coming weeks.

Fiscal-policy watchers awaited the cost of the drug plan, and how it might affect the federal government’s public finances in the years ahead. Freeland has pledged to keep the budget deficit this fiscal year to C$40 billion, and lower the debt-to-gross domestic product ratio after it peaks at 42.7% in 2024-25.

In a separate announcement, Canada said it would reallocate over the next three years about C$10.5 billion of spending from nonpriority items to top priorities, among them health care.

Holland said once initial negotiations are reached with the provinces and territories, that officials would examine whether other drugs could be covered.


Write to Paul Vieira at paul.vieira@wsj.com


Read the full article here

News Room March 1, 2024 March 1, 2024
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Morgan Stanley says wealthy clients ‘bought the dip’ amid tariff turmoil

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Gaza stampede at GHF aid site kills at least 20

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Bank of America boosted by bigger loan book and robust trading

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Diageo to replace chief executive Debra Crew after share price slump

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Nvidia chief vows to ‘accelerate recovery’ of China sales as H20 chip ban lifted

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Nursing Home Stocks Could Suffer from this Medicaid Spending Remedy

By News Room
Investing

Bitcoin Drops Below $90,000 Again. What Could Move It Next.

By News Room
Investing

These Stocks Are Moving the Most Today: Marvell, Nvidia, Broadcom, GM, Tesla, MongoDB, Burlington, and More

By News Room
Investing

Nvidia Stock Falls as Marvell Earnings Compound AI Gloom. The Rising Risks for Chips.

By News Room
Investing

This analyst says Tesla deliveries will be 16% below expectations. Musk is part of the problem.

By News Room
Investing

BP CEO was awarded no bonus pay from oil giant’s financial performance

By News Room
Investing

Shares of Starlink’s European competitor have tripled. CEO says it can do the job in Ukraine.

By News Room
Investing

GE Vernova Stock Rises as Analyst Flips to Upgrade After Rating Cut

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?